homocysteine and Diabetic Nephropathies

homocysteine has been researched along with Diabetic Nephropathies in 75 studies

Research

Studies (75)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	10 (13.33)	18.2507
2000's	43 (57.33)	29.6817
2010's	14 (18.67)	24.3611
2020's	8 (10.67)	2.80

Authors

Authors	Studies
Fouad, MM; Helmy, MA; Mahdy-Abdallah, H; Mansour, NAE; Shahy, EM; Taha, MM	1
Liu, D; Liu, J; Wu, J; Yang, L	1
Geng, X; Guo, Y; Ke, L	1
Cheng, W; Guo, J; Huang, AM; Li, H; Liang, J; Liu, C; Liu, Z; Wang, W; Yang, R; Zhang, J	1
Cheng, X; Liu, W; Ma, N; Wu, M; Xu, N; Yin, D	1
Dragnić, S; Kraljević, I; Mikhailidis, DP; Muzurović, E; Solak, M	1
Bu, S; Chu, Y; Dai, H; Hu, F; Hu, P; Qiu, X; Sha, W; Yang, X	1
Cao, Y; Jiang, Y; Kong, X; Li, P; Liu, P; Liu, Q; Ma, L; Yan, M; Zhang, H; Zhao, H; Zhao, T	1
Darwish, YW; El-Hamamsy, M; Elbarbary, NS; Ibrahim, MZ; Ismail, EAR; Zaki, MA	1
Cao, Y; Jiang, Y; Li, P; Liu, Q; Ma, L; Niu, W; Zhao, H; Zhao, T	1
Blaslov, K; Bulum, T; Duvnjak, L	1
Di, F; Gao, L; Jia, G; Li, N; Li, Q; Shao, J; Wang, L; Wang, Q	1
Barbieri, L; Cassetti, E; De Luca, G; Schaffer, A; Suryapranata, H; Verdoia, M	1
Ates, I; Barca, AN; Cetin, M; Kiziltunc, E; Kundi, H; Ornek, E; Ozkayar, N	1
Borettaz, I; D'angelo, A; Derosa, G; Esposito, P; Libetta, C; Maffioli, P; Tinelli, C	1
Kumar, M; Kundu, S; Rodriguez, WE; Sen, U; Tyagi, N; Tyagi, SC	1
Aso, Y	1
Eminagaoglu, S; Erem, C; Ersoz, HO; Hacihasanoglu, AB; Karahan, C; Kocak, M; Ukinc, K; Yilmaz, M	1
Almawi, WY; Jawad, LH; Juma, EA; Keleshian, SH; Nemr, R; Salman, RA	1
Sarnak, MJ; Shastri, S	1
Rabbani, N; Thornalley, PJ	1
Guo, XZ; Li, M; Lin, L	1
Jiang, ZT; Liang, QL; Wang, YM	1
Chen, J; Li, J; Shi, M; Xie, M; Yan, L; Zhang, H; Zhu, Y; Zhuang, L	1
Agarwal, A; Dubey, GP; Kumar, R; Rathore, SS; Singh, RG	1
Bàràny, P; Bergström, J; Heimbürger, O; Lindholm, B; Stenvinkel, P; Suliman, ME	1
Baba, T; Neugebauer, S; Parving, HH; Stehouwer, C; Tarnow, L; Teerlink, T; Watanabe, T	1
Bostom, AG; Friedman, AN; Hunsicker, LG; Selhub, J	2
Agulló-Ortuño, MT; Albaladejo, MD; Fenollar, M; Martínez, P; Parra, S; Rodríguez-Manotas, M; Ruíz-Espejo, F; Tebar, J	1
Cinapri, V; Fagnani, F; Giampietro, O; Mariani, S; Matteucci, E; Quilici, S; Rossi, L	1
Blazícek, P; Dzúrik, R; Gazdíková, K; Heidland, A; Schinzel, R; Sebeková, K; Spustová, V; Syrová, D	1
Fagot-Campagna, A; Gunter, EW; Hanson, RL; Knowler, WC; Looker, HC; Narayan, KM; Pfeiffer, CM	1
Aso, Y; Okumura, K	1
Angelini, GD; Jeremy, JY; Shukla, N	1
Clement, L	1
Lu, H; Sun, J; Xu, Y; Zhu, Y	1
Busch, M; Franke, S; Gerth, J; Müller, A; Niwa, T; Ott, U; Stein, G; Wolf, M	1
Aso, Y; Inukai, T; Matsutomo, R; Okumura, K; Takebayashi, K; Wakabayashi, S; Yoshida, N	1
Aggarwal, SP; Narang, AP; Sandhu, JS; Sandhu, P; Singh, I	1
Elias, AN; Eng, S	1
Ansquer, JC; Foucher, C; Rattier, S; Steiner, G; Taskinen, MR	1
Fowler, B; Herrmann, W; Kuhlmann, MK; Makowski, J; Obeid, R; Schorr, H	1
Alvarez González, A; Delgado, P; Hernández, D; Lorenzo, V; Pérez Tamajón, L; Sánchez Alvarez, JE	1
Coracina, A; Garibotto, G; Kiwanuka, E; Tessari, P; Valerio, A; Vedovato, M; Vettore, M; Zaramella, M	1
Falcone, JC; Fleming, JT; Joshua, IG; Passmore, JC; Rodriguez, WE; Tyagi, N; Tyagi, SC	1
Almawi, WY; Aouni, Z; Chaieb, A; Chaieb, M; Ezzidi, I; Mahjoub, T; Marmouche, H; Mtiraoui, N; Vaxillaire, M	1
Bennett, PH; Fagot-Campagna, A; Gunter, EW; Hanson, RL; Knowler, WC; Looker, HC; Nelson, RG; Pfeiffer, CM; Sievers, ML	1
Böger, CA; Christ, J; Götz, AK; Haak, T; Hoffmann, U; Krämer, BK; Riegger, GA; Stubanus, M	1
Allard, SE; Browne, DL; Cummings, MH; Laight, DW; Meeking, DR; Munday, LJ; Shaw, KM; Turner, C; Wotherspoon, F	1
Thaha, M; Tomino, Y; Yogiantoro, M	1
Alberghini, E; Baragetti, I; Buccianti, G; Buzzi, L; Catapano, AL; Furiani, S; Garlaschelli, K; Raselli, S; Stucchi, A; Terraneo, V	1
Agardh, CD; Agardh, E; Andersson, A; Hultberg, B	1
Amiral, J; Bierhaus, A; Borcea, V; Fiehn, W; Henkels, M; Hofmann, MA; Kohl, B; Nawroth, PP; Wahl, P; Ziegler, R; Zumbach, MS	1
Amiral, J; Bierhaus, A; Borcea, V; Fiehn, W; Henkels, M; Hofmann, MA; Kohl, B; Nawroth, PP; Schmidt, AM; Wahl, P; Ziegler, R; Zumbach, MS	1
Dennis, VW; Robinson, K	1
Arcelús, R; Blanco-Vaca, F; Carreras, G; Chico, A; Córdoba, A; de Leiva, A; González-Sastre, F; Pérez, A	1
Brouwer, CB; Silberbusch, J; Smulders, YM	1
Odekerken, DA; Rakic, M; Sijbrands, EJ; Silberbusch, J; Slaats, EH; Smulders, YM; Stehouwer, CD; Treskes, M	1
Allen, RH; Cohen, JA; Estacio, R; Jeffers, BW; Schrier, RW; Stabler, SP	1
Fukuda, S; Ichikawa, H; Makino, H; Nagake, Y; Oishi, K; Ota, K; Yamasaki, H	1
Fiedor, P; Polakowska, MJ; Socha, MW; Socha-Urbanek, K	1
Clague, A; Healy, H; Morgan, C; Reith, D; Westhuyzen, J	1
Chiarelli, F; Mohn, A; Morgese, G; Pomilio, M; Spagnoli, A; Tumini, S; Vanelli, M; Verrotti, A	1
Ben-Yehuda, A; Friedlander, Y; Friedman, G; Goldschmidt, N; Raz, I; Shpichinetsky, V; Wexler, ID	1
Buysschaert, M; Dramais, AS; Hermans, MP; Wallemacq, PE	1
Emoto, M; Inaba, M; Ishimura, E; Kanda, H; Kawagishi, T; Komatsu, M; Mori, K; Nishizawa, Y; Okuno, Y; Shoji, T; Tahara, H	1
Cuomo, V; Ingrosso, D; Iovine, C; Mancini, FP; Perna, AF; Riccardi, G; Rivellese, AA; Sacco, M; Tufano, A; Vaccaro, O	1
Chen, Y; Wang, J; Wang, L; Xue, Y; Zou, H	1
Brown, AT; Delongchamp, RR; Fink, LM; Fonseca, VA; Poirier, LA; Randolph, CJ; Wise, CK	1
Sun, J; Xu, Y; Zhu, Y	1
Emeis, JJ; Hovind, P; Parving, HH; Rossing, P; Stehouwer, CD; Tarnow, L; Teerlink, T	1
Caixàs, A; Deulofeu, R; Galdon, G; Giménez-Pérez, G; González-Clemente, JM; Mauricio, D; Mitjavila, J; Ortega, E	1
Bekpinar, S; Gürdöl, F; Seferoğlu, G; Unlüçerçi, Y	1
Agardh, CD; Agardh, E; Andersson, A; Brattström, L; Hultberg, B; Isaksson, A; Israelsson, B	1

Reviews

4 review(s) available for homocysteine and Diabetic Nephropathies

Article	Year
Homocysteine and diabetes: Role in macrovascular and microvascular complications. Journal of diabetes and its complications, 2021, Volume: 35, Issue:3 Topics: Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Vitamin B 12	2021
Cardiovascular disease in patients with diabetic nephropathy. Current molecular medicine, 2008, Volume: 8, Issue:6 Topics: Anemia; Arginine; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Enzyme Inhibitors; Glycation End Products, Advanced; Homocysteine; Humans; Prognosis; Risk Factors	2008
Homocysteine concentrations in patients with diabetes mellitus--relationship to microvascular and macrovascular disease. Diabetes, obesity & metabolism, 2005, Volume: 7, Issue:2 Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Homocysteine; Humans; Insulin; Microcirculation	2005
Hyperhomocysteinemia as a risk factor for cardiovascular diseases. The association of hyperhomocysteinemia with diabetes mellitus and renal transplant recipients. Annals of transplantation, 1999, Volume: 4, Issue:1 Topics: Cardiovascular Diseases; Diabetes Complications; Diabetic Nephropathies; Diabetic Retinopathy; Endothelium, Vascular; Heart Transplantation; Hemodynamics; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Kidney Transplantation; Risk Factors	1999

Trials

13 trial(s) available for homocysteine and Diabetic Nephropathies

Article	Year
Vitamin B complex supplementation as a homocysteine-lowering therapy for early stage diabetic nephropathy in pediatric patients with type 1 diabetes: A randomized controlled trial. Clinical nutrition (Edinburgh, Scotland), 2020, Volume: 39, Issue:1 Topics: Adolescent; Child; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dietary Supplements; Double-Blind Method; Female; Homocysteine; Humans; Male; Prospective Studies; Vitamin B Complex	2020
Effects of two different dialytic treatments on inflammatory markers in people with end-stage renal disease with and without type 2 diabetes mellitus. Cytokine, 2017, Volume: 92 Topics: Aged; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Homocysteine; Humans; Inflammation Mediators; Kidney Failure, Chronic; Lipoprotein(a); Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Receptor for Advanced Glycation End Products; Renal Dialysis	2017
[Effects of tangshen recipe on the homocysteine metabolism of patients with diabetic nephropathy]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2011, Volume: 31, Issue:8 Topics: Adult; Aged; Case-Control Studies; Diabetic Nephropathies; Dipeptides; Drugs, Chinese Herbal; Female; Homocysteine; Humans; Insulin; Male; Middle Aged; Phytotherapy	2011
Nephroprotective role of salacia chinensis in diabetic CKD patients: a pilot study. Indian journal of medical sciences, 2010, Volume: 64, Issue:8 Topics: Adult; Apolipoproteins B; Cholesterol; Creatinine; Diabetic Nephropathies; Homocysteine; Humans; Interleukin-6; Male; Middle Aged; Phytotherapy; Pilot Projects; Plant Preparations; Salacia; Triglycerides	2010
High plasma homocysteine concentrations are associated with plasma concentrations of thrombomodulin in patients with type 2 diabetes and link diabetic nephropathy to macroangiopathy. Metabolism: clinical and experimental, 2003, Volume: 52, Issue:11 Topics: Aged; Blood Glucose; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Endothelium, Vascular; Female; Homocysteine; Humans; Male; Middle Aged; Regression Analysis; Thrombomodulin	2003
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS). American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 45, Issue:3 Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Fenofibrate; Fibrinogen; Follow-Up Studies; Glycated Hemoglobin; Homocysteine; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Incidence; Male; Middle Aged; Models, Biological; Smoking; Treatment Outcome	2005
[Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2005, Volume: 25, Issue:3 Topics: Aged; Aged, 80 and over; Cohort Studies; Diabetic Nephropathies; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Prospective Studies; Renal Dialysis; Treatment Outcome; Vitamin B 12; Vitamin B 6	2005
Total plasma homocysteine and arteriosclerotic outcomes in type 2 diabetes with nephropathy. Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:11 Topics: Aged; Amlodipine; Antihypertensive Agents; Arteriosclerosis; Biphenyl Compounds; Cardiovascular System; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Double-Blind Method; Female; Homocysteine; Humans; Irbesartan; Male; Middle Aged; Placebos; Risk Factors; Smoking; Tetrazoles; Treatment Outcome	2005
Intravenous N-acetylcysteine during haemodialysis reduces the plasma concentration of homocysteine in patients with end-stage renal disease. Clinical drug investigation, 2006, Volume: 26, Issue:4 Topics: Acetylcysteine; Adult; Aged; Blood Pressure; Blood Proteins; Diabetic Nephropathies; Drug Administration Schedule; Female; Heart Rate; Hematocrit; Homocysteine; Humans; Hypertension; Infusions, Intravenous; Kidney Calculi; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Treatment Outcome; Urticaria	2006
Improvement of endothelial function in uraemic patients on peritoneal dialysis: a possible role for 5-MTHF administration. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:11 Topics: Aged; Diabetic Nephropathies; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Tetrahydrofolates; Ultrasonography; Uremia; Vasodilation	2007
Total homocysteine is associated with nephropathy in non-insulin-dependent diabetes mellitus. Metabolism: clinical and experimental, 1999, Volume: 48, Issue:9 Topics: Adult; Aged; Albuminuria; Cystathionine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Kidney Function Tests; Male; Methylmalonic Acid; Middle Aged; Regression Analysis; Vitamins	1999
Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy. Metabolism: clinical and experimental, 2001, Volume: 50, Issue:9 Topics: Adult; Albuminuria; Creatinine; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Disease Progression; Erythrocytes; Female; Homocysteine; Humans; Lymphocytes; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Reference Values; Regression Analysis; Renal Dialysis; S-Adenosylhomocysteine; S-Adenosylmethionine	2001
Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 38, Issue:6 Topics: Adult; Biomarkers; Cohort Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Male; Plasminogen Activator Inhibitor 1; Prospective Studies; Regression Analysis	2001

Other Studies

58 other study(ies) available for homocysteine and Diabetic Nephropathies

Article	Year
Preference between serum homocysteine and urinary periostin as early predictive biomarkers of renal dysfunction among uncontrolled diabetics. Journal of complementary & integrative medicine, 2022, Jun-01, Volume: 19, Issue:2 Topics: Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Homocysteine; Humans	2022
Association Between Serum Homocysteine Levels and Severity of Diabetic Kidney Disease in 489 Patients with Type 2 Diabetes Mellitus: A Single-Center Study. Medical science monitor : international medical journal of experimental and clinical research, 2022, Jun-10, Volume: 28 Topics: Albuminuria; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Homocysteine; Humans; Renal Insufficiency, Chronic	2022
Value of Color Doppler Ultrasonography for Diagnosing Early Diabetic Nephropathy. Iranian journal of kidney diseases, 2022, Volume: 16, Issue:5 Topics: Albumins; Blood Glucose; Cystatin C; Diabetes Mellitus; Diabetic Nephropathies; Glycated Hemoglobin; Homocysteine; Humans; Ultrasonography, Doppler; Ultrasonography, Doppler, Color; Uric Acid	2022
The association of homocysteine level with the risk of diabetic nephropathy and diabetic retinopathy in NHANES. Acta diabetologica, 2023, Volume: 60, Issue:7 Topics: Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Homocysteine; Humans; Kidney Function Tests; Nutrition Surveys; Risk Factors	2023
Relationship between plasma total homocysteine and the severity of renal function in Chinese patients with type 2 diabetes mellitus aged ≥75 years. Medicine, 2020, Jul-02, Volume: 99, Issue:27 Topics: Age Factors; Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Homocysteine; Humans; Kidney; Male; Middle Aged; Risk Factors; Severity of Illness Index	2020
Lower expression of Hsa_circRNA_102682 in diabetic hyperhomocysteinemia negatively related to creatinemia is associated with TGF-β and CTGF. Journal of clinical laboratory analysis, 2021, Volume: 35, Issue:8 Topics: Connective Tissue Growth Factor; Creatinine; Diabetic Nephropathies; Gene Expression Regulation; Homocysteine; Humans; Hyperhomocysteinemia; Middle Aged; RNA, Circular; ROC Curve; Transforming Growth Factor beta	2021
Association of Journal of diabetes research, 2018, Volume: 2018 Topics: Aged; Alleles; Case-Control Studies; China; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Epoxide Hydrolases; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Haplotypes; Homocysteine; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide	2018
Genetically elevated circulating homocysteine concentrations increase the risk of diabetic kidney disease in Chinese diabetic patients. Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:4 Topics: Asian People; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Follow-Up Studies; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Prognosis; Risk Factors	2019
Plasma Homocysteine is Associated with Retinopathy in Type 1 Diabetic Patients in the Absence of Nephropathy. Seminars in ophthalmology, 2016, Volume: 31, Issue:3 Topics: Adult; Aged; Albuminuria; Blood Glucose; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Homocysteine; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Young Adult	2016
Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus. PloS one, 2015, Volume: 10, Issue:11 Topics: Adult; Aged; Albuminuria; Comorbidity; Cytokines; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fatty Acids, Nonesterified; Female; Glomerular Filtration Rate; GPI-Linked Proteins; Homocysteine; Humans; Incidence; Insulin Resistance; Lectins; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Retrospective Studies; Risk Factors; Tumor Necrosis Factor-alpha; Uric Acid	2015
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study. Annals of nutrition & metabolism, 2016, Volume: 68, Issue:3 Topics: Age Factors; Aged; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Diabetic Angiopathies; Diabetic Cardiomyopathies; Diabetic Nephropathies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Hypertriglyceridemia; Italy; Male; Middle Aged; Prevalence; Renal Insufficiency; Risk Factors; Severity of Illness Index; Smoking	2016
Association between plasma homocysteine levels and end-organ damage in newly diagnosed type 2 diabetes mellitus patients. Endocrine research, 2017, Volume: 42, Issue:1 Topics: Aged; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Cardiomyopathies; Diabetic Nephropathies; Female; Homocysteine; Humans; Male; Middle Aged	2017
Ciglitazone, a PPARgamma agonist, ameliorates diabetic nephropathy in part through homocysteine clearance. American journal of physiology. Endocrinology and metabolism, 2008, Volume: 295, Issue:5 Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epinephrine; Gene Expression; Glomerular Filtration Rate; Homocysteine; Hypoglycemic Agents; Kidney Tubules; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Nitric Oxide; PPAR gamma; Renal Artery; Renal Circulation; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-4; Tissue Inhibitor of Metalloproteinases; Vascular Resistance; Vasoconstriction	2008
Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy. Endocrine, 2009, Volume: 36, Issue:2 Topics: Adult; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Disease Susceptibility; Female; Gene Frequency; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Point Mutation; Polymorphism, Single Nucleotide; Risk Factors	2009
Differential contribution of MTHFR C677T variant to the risk of diabetic nephropathy in Lebanese and Bahraini Arabs. Clinical chemistry and laboratory medicine, 2010, Volume: 48, Issue:8 Topics: Adult; Alleles; Amino Acid Substitution; Arabs; Bahrain; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Lebanon; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide	2010
Cardiovascular disease and CKD: core curriculum 2010. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2010, Volume: 56, Issue:2 Topics: Acute Coronary Syndrome; Anemia; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Cardiac Catheterization; Cardiovascular Diseases; Cholesterol, LDL; Comorbidity; Diabetic Nephropathies; Dyslipidemias; Electrocardiography; Heart Failure; Heart Valve Diseases; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Life Style; Myocardial Ischemia; Oxidative Stress; Pericarditis; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Smoking; Troponin T	2010
Therapy: Vitamin B6, B9 and B12 in diabetic nephropathy--beware. Nature reviews. Endocrinology, 2010, Volume: 6, Issue:9 Topics: Cardiovascular Diseases; Diabetic Nephropathies; Disease Progression; Down-Regulation; Folic Acid; Homocysteine; Humans; Randomized Controlled Trials as Topic; Vitamin B 12; Vitamin B 6; Vitamins	2010
[Analysis on relationship of Chinese medicine syndrome pattern with urinary albumin excretion rate and its related factors in early stage diabetic nephropathy]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2010, Volume: 30, Issue:9 Topics: Adult; Aged; Albuminuria; Diabetic Nephropathies; Diagnosis, Differential; Female; Homocysteine; Humans; Male; Medicine, Chinese Traditional; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic	2010
Relation of homocysteine to early nephropathy in patients with Type 2 diabetes. Clinical nephrology, 2012, Volume: 77, Issue:4 Topics: Adult; Aged; Albuminuria; Algorithms; Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diagnosis, Differential; Early Diagnosis; Female; Homocysteine; Humans; Inpatients; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity; Surveys and Questionnaires	2012
Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 40, Issue:3 Topics: Adult; Amino Acids, Sulfur; Cardiovascular Diseases; Cross-Sectional Studies; Cysteine; Deficiency Diseases; Diabetic Nephropathies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methionine; Middle Aged; Nutrition Assessment; Nutrition Disorders; Nutritional Status; Prevalence; Protein-Energy Malnutrition; Renal Dialysis; Serum Albumin	2002
Total plasma homocysteine is associated with hypertension in Type I diabetic patients. Diabetologia, 2002, Volume: 45, Issue:9 Topics: Adult; Albuminuria; Body Mass Index; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Female; Genotype; Glomerular Filtration Rate; Homocysteine; Humans; Hypertension; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Risk Factors	2002
Proteinuria as a predictor of total plasma homocysteine levels in type 2 diabetic nephropathy. Diabetes care, 2002, Volume: 25, Issue:11 Topics: Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proteinuria	2002
Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus. Clinica chimica acta; international journal of clinical chemistry, 2002, Volume: 326, Issue:1-2 Topics: Adult; Aged; Analysis of Variance; Biomarkers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Regression Analysis	2002
Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives. Nutrition, metabolism, and cardiovascular diseases : NMCD, 2002, Volume: 12, Issue:4 Topics: Adult; Aged; Case-Control Studies; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Homocysteine; Humans; Male; Middle Aged; Sex Factors; Smoking	2002
Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products. Journal of human hypertension, 2003, Volume: 17, Issue:4 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Glucose; Blood Pressure; Creatinine; Cystatin C; Cystatins; Diabetic Nephropathies; Female; Glomerulonephritis; Glycation End Products, Advanced; Homocysteine; Humans; Lipofuscin; Lysine; Male; Malondialdehyde; Middle Aged; Nephritis, Interstitial; Oxidative Stress; Polycystic Kidney Diseases; Ramipril; Severity of Illness Index; Statistics as Topic; Treatment Outcome	2003
Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes. Diabetologia, 2003, Volume: 46, Issue:6 Topics: Age Factors; Analysis of Variance; Arizona; Biomarkers; Blood Glucose; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Folic Acid; Homocysteine; Humans; Incidence; Indians, North American; Longitudinal Studies; Male; Middle Aged; Vitamin B 12	2003
To: Looker HC, Fagot-Campagna A, Gunter EW et al. (2003) Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes. Diabetologia 46:766-772. Diabetologia, 2004, Volume: 47, Issue:1 Topics: Animals; Diabetic Angiopathies; Diabetic Nephropathies; Homocysteine; Humans; Hyperhomocysteinemia; Models, Animal; Rabbits; Risk Factors	2004
Evidence suggests diabetes outcomes linked to homocysteine. Nephrology news & issues, 2003, Volume: 17, Issue:13 Topics: Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B Complex	2003
Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes research and clinical practice, 2004, Volume: 64, Issue:3 Topics: Asian People; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Spectrometry, Fluorescence	2004
Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein. Kidney international, 2004, Volume: 66, Issue:1 Topics: Aged; Arteriosclerosis; C-Reactive Protein; Case-Control Studies; Chronic Disease; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Homocysteine; Humans; Kidney Diseases; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Renal Dialysis; Risk Factors; Thrombosis	2004
Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia. Clinica chimica acta; international journal of clinical chemistry, 2004, Volume: 348, Issue:1-2 Topics: Albuminuria; alpha-2-Antiplasmin; Biomarkers; Blood Coagulation; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Interleukin-6; Linear Models; Male; Middle Aged; Protein C	2004
Plasma homocysteine and insulin in diabetic nephropathy: relationship to body mass index. Renal failure, 2004, Volume: 26, Issue:6 Topics: Adult; Aged; Biomarkers; Blood Glucose; Body Mass Index; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Homocysteine; Humans; Insulin; Male; Middle Aged; Prospective Studies; Reference Values; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index	2004
Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes. Clinical chemistry, 2005, Volume: 51, Issue:5 Topics: Aged; Cystathionine; Cysteine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Folic Acid; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Male; Methionine; Methylmalonic Acid; Middle Aged; S-Adenosylhomocysteine; S-Adenosylmethionine; Transcobalamins; Vitamin B 12; Vitamin B 6	2005
Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy. Diabetes, 2005, Volume: 54, Issue:10 Topics: Blood Glucose; Carbon Dioxide; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fasting; Food; Glucose Clamp Technique; Glycated Hemoglobin; Heterozygote; Homocysteine; Homozygote; Humans; Insulin; Kinetics; Male; Methionine; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Sulfur	2005
Pioglitazone mitigates renal glomerular vascular changes in high-fat, high-calorie-induced type 2 diabetes mellitus. American journal of physiology. Renal physiology, 2006, Volume: 291, Issue:3 Topics: Animals; Arterioles; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dietary Fats; Hemodynamics; Homocysteine; Kidney Glomerulus; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Nitric Oxide; Oxidative Stress; Phenylephrine; Pioglitazone; Thiazolidinediones	2006
MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients. Diabetes research and clinical practice, 2007, Volume: 75, Issue:1 Topics: Adult; Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Tunisia	2007
Homocysteine and vitamin B(12) concentrations and mortality rates in type 2 diabetes. Diabetes/metabolism research and reviews, 2007, Volume: 23, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Arizona; Cardiovascular Diseases; Cause of Death; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Folic Acid; Homocysteine; Humans; Indians, North American; Infections; Longitudinal Studies; Male; Middle Aged; Proportional Hazards Models; Serum Albumin; Vitamin B 12	2007
Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:1 Topics: Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dietary Supplements; Disease Progression; Female; Genotype; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Phenotype; Polymorphism, Single Nucleotide; Time Factors	2007
Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria. Diabetic medicine : a journal of the British Diabetic Association, 2006, Volume: 23, Issue:12 Topics: Adult; Albuminuria; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Endothelium, Vascular; Female; Homocysteine; Humans; Male; Oxidative Stress	2006
Lack of association between plasma homocysteine levels and microangiopathy in type 1 diabetes mellitus. Scandinavian journal of clinical and laboratory investigation, 1994, Volume: 54, Issue:8 Topics: Adult; Albuminuria; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Homocysteine; Humans; Male; Middle Aged; Vitamin B 12	1994
Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes care, 1997, Volume: 20, Issue:12 Topics: Administration, Oral; Adult; Albuminuria; Case-Control Studies; Cells, Cultured; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Endothelium, Vascular; Female; Homocysteine; Homocystine; Humans; Male; Methionine; Middle Aged; Reference Values; Thrombomodulin	1997
Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes care, 1998, Volume: 21, Issue:5 Topics: Adult; Aged; Albuminuria; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Drug Synergism; Endothelium, Vascular; Fasting; Female; Glycation End Products, Advanced; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Thrombomodulin	1998
From microalbuminuria to hyperhomocysteinemia. Kidney international, 1998, Volume: 54, Issue:1 Topics: Albuminuria; Diabetic Nephropathies; Disease Progression; Homocysteine; Humans	1998
Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia, 1998, Volume: 41, Issue:6 Topics: Adult; Aged; Albuminuria; Analysis of Variance; Biomarkers; Body Mass Index; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Homocysteine; Humans; Hypertension; Lipids; Lipoproteins; Male; Middle Aged; Proteinuria; Regression Analysis; Vitamins	1998
Is plasma homocysteine related to albumin excretion rate in patients with diabetes mellitus? Diabetologia, 1999, Volume: 42, Issue:3 Topics: Albuminuria; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Homocysteine; Humans	1999
Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes care, 1999, Volume: 22, Issue:1 Topics: Administration, Oral; Adult; Aged; Albuminuria; Analysis of Variance; Blood Pressure; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Fasting; Female; Folic Acid; Homocysteine; Humans; Male; Methionine; Middle Aged; Postmenopause; Premenopause; Pyridoxal Phosphate; Regression Analysis; Risk Factors; Vitamin B 12	1999
The significance of serum homocysteine levels in diabetic patients on haemodialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15, Issue:6 Topics: Aged; Arteriosclerosis; Biomarkers; Creatinine; Diabetic Angiopathies; Diabetic Nephropathies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Risk Factors; Serum Albumin	2000
Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure? Annals of clinical and laboratory science, 2000, Volume: 30, Issue:3 Topics: Acute-Phase Proteins; Adult; Aged; Analysis of Variance; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus; Diabetic Nephropathies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Metalloproteins; Middle Aged; Prevalence; Regression Analysis; Renal Dialysis; Risk Factors	2000
Homocysteine levels during fasting and after methionine loading in adolescents with diabetic retinopathy and nephropathy. The Journal of pediatrics, 2000, Volume: 137, Issue:3 Topics: Adolescent; Adult; Age of Onset; Albuminuria; Child; Cholesterol, LDL; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Fasting; Female; Homocysteine; Humans; Lipoprotein(a); Male; Methionine; Regression Analysis; Statistics, Nonparametric	2000
The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients. The Journal of nutrition, 2000, Volume: 130, Issue:10 Topics: Aged; Albuminuria; Alleles; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Folic Acid; Gene Frequency; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors	2000
Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes care, 2000, Volume: 23, Issue:12 Topics: Aged; Cohort Studies; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Folic Acid; Homeostasis; Homocysteine; Humans; Hyperhomocysteinemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Logistic Models; Male; Metabolic Clearance Rate; Metformin; Middle Aged; Vitamin B 12	2000
Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes care, 2001, Volume: 24, Issue:3 Topics: Blood Glucose; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glucose Clamp Technique; Glycated Hemoglobin; Homocysteine; Humans; Infusions, Intravenous; Insulin; Insulin Resistance; Male; Middle Aged; Reference Values; Regression Analysis; Uric Acid	2001
Plasma homocysteine and microvascular complications in type 1 diabetes. Nutrition, metabolism, and cardiovascular diseases : NMCD, 2000, Volume: 10, Issue:6 Topics: Adult; Albuminuria; Case-Control Studies; Creatinine; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Folic Acid; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Vitamin B 12	2000
[Relationship between methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2001, Volume: 18, Issue:4 Topics: Asian People; Diabetic Nephropathies; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length	2001
[The association of methylenetetrahydrofolate reductase gene polymorphism with nephropathy in type 2 diabetes mellitus in Chinese]. Zhonghua nei ke za zhi, 2001, Volume: 40, Issue:8 Topics: Adult; Alleles; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic	2001
Plasma homocysteine is not increased in microalbuminuric patients with type 2 diabetes without clinical cardiovascular disease. Diabetes care, 2002, Volume: 25, Issue:3 Topics: Aged; Albuminuria; Blood Glucose; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Homocysteine; Humans; Male; Middle Aged; Reference Values	2002
A study on the relationship between homocysteine and diabetic nephropathy in rats. Pharmacological research, 2002, Volume: 45, Issue:3 Topics: Animals; Creatinine; Diabetic Nephropathies; Enzyme Inhibitors; Glycation End Products, Advanced; Glycosaminoglycans; Guanidines; Homocysteine; Male; Rats; Rats, Wistar	2002
Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus. Scandinavian journal of clinical and laboratory investigation, 1991, Volume: 51, Issue:3 Topics: Adult; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Homocysteine; Humans; Male; Middle Aged	1991